Exercise Capacity Assessment

Exercise capacity assessment measures patient functional status and exercise tolerance informing therapeutic efficacy in cardiovascular and pulmonary diseases. Six-minute walk tests quantitate distance ambulated providing functional capacity measurement. Cardiopulmonary exercise testing measures maximal oxygen consumption and anaerobic threshold. Quality-of-life assessments capture subjective exercise tolerance perceptions.

Clinical trials employ exercise capacity endpoints demonstrating therapeutic benefit. Baseline assessment establishes disease severity guiding prognostic prediction. Longitudinal monitoring detects exercise improvement or deterioration. Regulatory submissions highlight exercise capacity improvements demonstrating patient benefit. Post-approval monitoring confirms real-world efficacy reflecting trial outcomes.